132 related articles for article (PubMed ID: 38616463)
21. Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors.
Dong S; Liang J; Zhai W; Yu Z
Am J Clin Oncol; 2020 Sep; 43(9):607-614. PubMed ID: 32889829
[TBL] [Abstract][Full Text] [Related]
22. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract][Full Text] [Related]
23. Novel nomogram predicting cancer-specific survival and overall survival in patients with primary esophageal small-cell carcinoma: A surveillance, epidemiology, and end results-based study.
Li J; Yu H; Peng L; Li L; Wang X; Hao J; Shao N
J Cancer Res Ther; 2021 Jul; 17(3):630-637. PubMed ID: 34269292
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a nomogram to predict long-term cancer-specific survival for patients with osteosarcoma.
Yu Y; Wang S; Liu J; Ge J; Guan H
Sci Rep; 2023 Jun; 13(1):10230. PubMed ID: 37353555
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases.
Wang T; Liu C; Wang W; Huang B; Yu R; Huang M; Dong W
Transl Cancer Res; 2022 Jun; 11(6):1534-1551. PubMed ID: 35836507
[TBL] [Abstract][Full Text] [Related]
26. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
Huang X; Hu P; Yan F; Zhang J
Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
[No Abstract] [Full Text] [Related]
27. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
[TBL] [Abstract][Full Text] [Related]
28. Prognostic models for predicting overall and cancer-specific survival of patients with initially diagnosed metastatic cervical squamous cell carcinoma: A study based on SEER database.
Ding R; Su Z; Chen M; Chen L
Medicine (Baltimore); 2023 Jul; 102(28):e34313. PubMed ID: 37443499
[TBL] [Abstract][Full Text] [Related]
29. Independent risk factors evaluation for overall survival and cancer-specific survival in thyroid cancer patients with bone metastasis: A study for construction and validation of the predictive nomogram.
Tong Y; Huang Z; Hu C; Chi C; Lv M; Li P; Zhao C; Song Y
Medicine (Baltimore); 2020 Sep; 99(36):e21802. PubMed ID: 32899008
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of nomogram models for predicting overall survival and cancer-specific survival in gastric cancer patients with liver metastases: a cohort study based on the SEER database.
Meng N; Niu X; Wu J; Wu H; Li T; Yang J; Ding P; Guo H; Tian Y; Yang P; Zhang Z; Wang D; Zhao Q
Am J Cancer Res; 2024; 14(5):2272-2286. PubMed ID: 38859846
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of two nomograms for predicting overall survival and cancer-specific survival in gastric cancer patients with liver metastases: A retrospective cohort study from SEER database.
Dong Z; Zhang Y; Geng H; Ni B; Xia X; Zhu C; Liu J; Zhang Z
Transl Oncol; 2022 Oct; 24():101480. PubMed ID: 35868142
[TBL] [Abstract][Full Text] [Related]
32. Nomogram predicting survival in patients with lymph node-negative hepatocellular carcinoma based on the SEER database and external validation.
Li Z; Hong Q; Li K
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):904-915. PubMed ID: 38652516
[TBL] [Abstract][Full Text] [Related]
33. Prognostic nomogram for predicting long-term cancer-specific survival in patients with lung carcinoid tumors.
He Y; Zhao F; Han Q; Zhou Y; Zhao S
BMC Cancer; 2021 Feb; 21(1):141. PubMed ID: 33557782
[TBL] [Abstract][Full Text] [Related]
34. Early distinction of lymph node metastasis in patients with soft tissue sarcoma and individualized survival prediction using the online available nomograms: A population-based analysis.
Tong Y; Pi Y; Cui Y; Jiang L; Gong Y; Zhao D
Front Oncol; 2022; 12():959804. PubMed ID: 36568161
[TBL] [Abstract][Full Text] [Related]
35. Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell Lung Cancer Receiving Radiotherapy: A Population-Based Study.
Li P; Luo J; Zheng Z; Meng L; Zhang A; Cao W; Gong X
Cancer Control; 2024; 31():10732748241255212. PubMed ID: 38769789
[TBL] [Abstract][Full Text] [Related]
36. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
[TBL] [Abstract][Full Text] [Related]
37. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
[TBL] [Abstract][Full Text] [Related]
40. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
